EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
news

Patients once thought incurable can benefit from high-dose radiation therapy

In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase ...
Continue Reading →
news

Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps

Dupixent significantly reduced nasal polyp size, nasal congestion severity, and need for systemic corticosteroids and/or surgery Dupixent has now demonstrated ...
Continue Reading →
Asia Pacific

Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis

Servier, an independent international pharmaceutical company, and the company Galapagos NV announce the start of a global Phase 2 trial with S201086/GLPG1972 in knee...
Continue Reading →
news

AbbVie Provides Update on Phase 3 Study of Ibrutinib in Blood Cancer Diffuse Large B-Cell Lymphoma and Ongoing Ibrutinib Clinical Program

AbbVie , a research-based global biopharmaceutical company, announced an update on a Phase 3 study (DBL3001) of ibrutinib (IMBRUVICA®) in untreated diffuse large B-c...
Continue Reading →
news

Pivotal Clinical Trial Costs Estimated at $19 Million

A new analysis has found it costs an average of $19 million to get new drugs through pivotal clinical trials and onto the market. Researchers at the Institute for Saf...
Continue Reading →
news

New cancer vaccine may tackle HER2-positive tumors

New research shows that a new cancer vaccine may be effective for treating a range of HER2-positive cancers, including the more aggressive HER2-positive breast cancer...
Continue Reading →
Europe

Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies

GB Sciences and Catalent tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease. SWINDO...
Continue Reading →
news

Companies join forces to showcase how AI algorithms can progressively be adopted in study conduct, at DPharm 2018

Pioneering partners Cmed and Innovative Physics have combined forces to showcase The Real Time Medical Imaging Users Tool Kit®, which uses artificial intelligence to ...
Continue Reading →
news

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

PCI Expands Clinical Services’ presence with acquisition of California-based Sherpa Clinical Packaging Philadelphia, USA – September 10, 2018 Leading global biopharm...
Continue Reading →
news

PCI Announces Expansion of its Industry-Leading Cold Chain Infrastructure with Dedicated -40°C Facility

PCI Clinical Services purpose-built state-of-the-art Cold Chain facility opens in Rockford, IL Philadelphia, USA – August 29, 2018 PCI Pharma Services (PCI), a full-...
Continue Reading →
Quotient